EXALTA Group, a global leader in the development and manufacturing of integrated OEM solutions for mission-critical medical devices, today announced it has obtained European Medical Device Regulation (EU-MDR) certification for its full range of headed and headless titanium compression screws used in trauma and reconstructive surgery.
Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever.
At The MedTech Digest, we believe in spotlighting the founders and technologies shaping the future of
healthcare. Our team at MedTech Momentum is honored to support XLTA as you bring XLTA®
Hydrocapillary Triple-Action™ technology to the U.S. market.
Some of the most innovative leaders in the Medical Technology industry don’t arrive there through a straight line, and that’s certainly the case with Brian Kieser. Before founding Nvision Biomedical Technologies and building one of the most integrated innovation ecosystems in the industry, Brian was a mechanical engineering student, then an accountant, and eventually a certified public accountant (CPA) at KPMG. From technical schematics to financial audits, he’s seen every layer of how a business is built successfully.
We sit down with Brian More, CEO of Nanovis, for a candid conversation on strategy, science, and scaling up smart. From startup grit to a groundbreaking collaboration with Medtronic, Brian shares how Nanovis is transforming orthopedic and spinal implants through surface-level innovation, and why staying focused is the key to long-term success.
Founded as a spin-out from the University of Oxford, Brainomix has already transformed stroke care across Europe. With more than 70% market share in the UK and over 60 peer-reviewed publications validating its efficacy in real world settings, the company has delivered what few others can: evidence-based, scalable AI that improves outcomes and makes stroke systems more efficient.
“We often joke that we’re the Green Berets of quality,” says Monica Burt, founder of MB&A. “When things go sideways—an FDA audit is imminent, a system is unraveling, or a product launch is on life support—we get the call.”In this candid conversation with The MedTech Digest, Monica Burt pulls back the curtain on why most MedTech companies are doing quality all wrong—and how her team is helping them fix it before it breaks them. From debunking the myth that more paperwork equals more compliance, to rebuilding systems that actually enable innovation, Burt’s insights are equal parts sharp, strategic, and human.
MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.
MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.
In an era defined by geopolitical maneuvering and protectionist impulses, European MedTech companies now face a pivotal moment. The U.S. administration’s latest proposal to impose steep tariffs on multiple countries worldwide, including European imports, is not just a policy tweak; it is a signal of a return to a high-stakes trade environment reminiscent of history’s […]
